MedTrace Logo

Change in Inflammatory State in Patients Undergoing Transcatheter Ablation of Atrial Fibrillation

NCT05961865 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2023-09-13

No results posted yet for this study

Summary

It is a non-pharmacological (biological), spontaneous observational study. The main objective is to evaluate the correlation between inflammation markers and local adiposity, clinical risk factors and their possible variation following an AF ablation procedure

Conditions

Interventions

DIAGNOSTIC_TEST

Markers of inflammation and fibrosis

Will be analyzed the following inflammation markers: Interleukin 6, N-terminal propeptide of type 1 procollagen (P1NP), chitinase-3-like protein 1 (YKL-40), tumor necrosis factor (TNF-alpha), GlycA, proprotein convertase subtilisin/kexin type 9 and omega-3 fatty acids.

Sponsors & Collaborators

  • University of Milan

    collaborator OTHER

  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

    lead OTHER

Principal Investigators

  • Stefano Carugo, MD · IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-11
Primary Completion
2027-07-31
Completion
2027-08-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05961865 on ClinicalTrials.gov